Searching... please wait. You've got 417 hits!
Acronym | Full Name | Score | Rating | Judge me | Search |
PI | phosphatidylinositol | 289 | 2 | good bad | |
PI | phosphate | 232 | -2 | good bad | |
PI | Propidium iodide | 224 | 6 | good bad | |
PI | point | 120 | -2 | good bad | |
PI | phosphoinositide | 86 | 3 | good bad | |
PI | postinoculation | 67 | 2 | good bad | |
PI | points | 50 | 10 | good bad | |
PI | postinfection | 50 | 1 | good bad | |
PI | proliferation index | 46 | 1 | good bad | |
PI | proliferative index | 39 | 1 | good bad | |
PI | protease inhibitors | 38 | 6 | good bad | |
PI | persistently infected | 26 | 3 | good bad | |
PI | post infection | 25 | 0 | good bad | |
PI | post inoculation | 24 | 0 | good bad | |
PI | phosphatidyl inositol | 23 | 6 | good bad | |
PI | post-infection | 23 | -1 | good bad | |
PI | post-inoculation | 19 | 2 | good bad | |
PI | pressure | 15 | 7 | good bad | |
PI | proactive interference | 13 | 5 | good bad | |
PI | ponderal index | 10 | 1 | good bad | |
PI | phagocytic index | 9 | 2 | good bad | |
PI | proinsulin | 8 | 0 | good bad | |
PI | permeability index | 7 | 3 | good bad | |
PI | proliferating index | 7 | 1 | good bad | |
PI | pain intensity | 7 | -1 | good bad | |
PI | pulsatility | 6 | 4 | good bad | |
PI | perfusion imaging | 6 | 1 | good bad | |
PI | porcine insulin | 5 | 5 | good bad | |
PI | phosphocreatine (PCr) to inorganic phosphate | 5 | 5 | good bad | |
PI | PISTILLATA | 5 | 4 | good bad | |
PI | plaque | 5 | 4 | good bad | |
PI | perfusion index | 5 | 3 | good bad | |
PI | povidone iodine | 5 | 2 | good bad | |
PI | Pneumatosis intestinalis | 5 | 2 | good bad | |
PI | penetration index | 5 | 1 | good bad | |
PI | phosphatidyl-inositol | 5 | 1 | good bad | |
PI | phosphotyrosine interaction | 5 | 0 | good bad | |
PI | performance index | 5 | 0 | good bad | |
PI | postinjection | 4 | 8 | good bad | |
PI | 1-protease inhibitor | 4 | 6 | good bad | |
PI | pulvinar | 4 | 6 | good bad | |
PI | polyphosphoinositide | 4 | 4 | good bad | |
PI | Persistent infection | 4 | 3 | good bad | |
PI | pork insulin | 4 | 1 | good bad | |
PI | Principal Investigator | 4 | 0 | good bad | |
PI | Proliferation indices | 4 | 0 | good bad | |
PI | plasma insulin | 4 | 0 | good bad | |
PI | Protein I | 4 | -2 | good bad | |
PI | proteinase inhibitors | 3 | 8 | good bad | |
PI | performance improvement | 3 | 7 | good bad | |
PI | pars intercerebralis | 3 | 6 | good bad | |
PI | protein intake | 3 | 5 | good bad | |
PI | phosphatidylinositide | 3 | 5 | good bad | |
PI | proportional-integral | 3 | 3 | good bad | |
PI | putatively immune | 3 | 3 | good bad | |
PI | peripheral iridectomy | 3 | 2 | good bad | |
PI | Phosphocreatine (PCr) and inorganic phosphate | 3 | 2 | good bad | |
PI | presence of inorganic phosphate | 3 | 2 | good bad | |
PI | promoter I | 3 | 2 | good bad | |
PI | pulsatility indexes | 3 | 1 | good bad | |
PI | pentamidine isethionate | 3 | 1 | good bad | |
PI | povidone-iodine | 3 | 0 | good bad | |
PI | pulse index | 3 | 0 | good bad | |
PI | post injection | 3 | -1 | good bad | |
PI | primary isolates | 3 | -2 | good bad | |
PI | Prevotella intermedia | 3 | -2 | good bad | |
PI | pressure intercept | 3 | -2 | good bad | |
PI | post instillation | 2 | 8 | good bad | |
PI | Pacific Islanders | 2 | 7 | good bad | |
PI | Pharmacoeconomic Initiative | 2 | 6 | good bad | |
PI | proliferation indexes | 2 | 5 | good bad | |
PI | proactive inhibition | 2 | 5 | good bad | |
PI | pristinamycin I | 2 | 5 | good bad | |
PI | alpha | 2 | 5 | good bad | |
PI | phosphatidic acid (PA) and phosphatidylinositol | 2 | 4 | good bad | |
PI | position of inorganic orthophosphate | 2 | 4 | good bad | |
PI | orthophosphate | 2 | 4 | good bad | |
PI | pulmonary insufficiency | 2 | 3 | good bad | |
PI | postimplantation | 2 | 3 | good bad | |
PI | psychodynamic-interpersonal | 2 | 2 | good bad | |
PI | glycosyl-phosphatidylinositol | 2 | 2 | good bad | |
PI | alpha-1-proteinase inhibitor | 2 | 2 | good bad | |
PI | post insemination | 2 | 2 | good bad | |
PI | plasma infusion | 2 | 2 | good bad | |
PI | positive index | 2 | 1 | good bad | |
PI | postinspiratory | 2 | 1 | good bad | |
PI | peroxidizability index | 2 | 1 | good bad | |
PI | primary infection | 2 | 1 | good bad | |
PI | pancreatic islets | 2 | 1 | good bad | |
PI | progression index | 2 | 1 | good bad | |
PI | perceptual identification | 2 | 1 | good bad | |
PI | phosphatidylinositols | 2 | 0 | good bad | |
PI | pulsation index | 2 | 0 | good bad | |
PI | pulsatile index | 2 | 0 | good bad | |
PI | pulsitility index | 2 | 0 | good bad | |
PI | phosphorous | 2 | 0 | good bad | |
PI | personality inventory | 2 | 0 | good bad | |
PI | proportional integral | 2 | 0 | good bad | |
PI | plant introduction | 2 | -1 | good bad | |
PI | p85 regulatory subunit of phosphatidylinositol | 2 | -1 | good bad | |
PI | Protection Index | 2 | -1 | good bad | |
PI | Phosphatidylglycerol (PG) and phosphatidylinositol | 2 | -1 | good bad | |
PI | preparatory intervals | 2 | -1 | good bad | |
PI | peptide that stimulates phosphoinositide | 2 | -2 | good bad | |
PI | pathogenicity island | 2 | -2 | good bad | |
PI | protracted infusion | 2 | -2 | good bad | |
PI | proteins with isoelectric points | 2 | -2 | good bad | |
PI | proteins and phosphatidylinositol | 1 | 10 | good bad | |
PI | pregnane indices | 1 | 9 | good bad | |
PI | protein in a phosphorylated form | 1 | 9 | good bad | |
PI | proportionality index | 1 | 9 | good bad | |
PI | pipobroman | 1 | 9 | good bad | |
PI | peak | 1 | 8 | good bad | |
PI | pearling index | 1 | 8 | good bad | |
PI | photoxic index | 1 | 8 | good bad | |
PI | pig insulin | 1 | 8 | good bad | |
PI | postischemic | 1 | 8 | good bad | |
PI | Polyinosinic acid | 1 | 7 | good bad | |
PI | performance/intensity | 1 | 7 | good bad | |
PI | performance indices | 1 | 7 | good bad | |
PI | Platelet inhibition | 1 | 7 | good bad | |
PI | presence of Ca2+ and phosphate | 1 | 7 | good bad | |
PI | peak increase | 1 | 7 | good bad | |
PI | postoperative ileus | 1 | 6 | good bad | |
PI | persists 6 weeks postinfection | 1 | 6 | good bad | |
PI | phosphatidylinositol membrane anchor | 1 | 6 | good bad | |
PI | protease inhibitor 1 | 1 | 6 | good bad | |
PI | PDGF-stimulated binding of phosphatidylinositol | 1 | 6 | good bad | |
PI | PPi and as inorganic orthophosphate | 1 | 6 | good bad | |
PI | postintraocular injection | 1 | 6 | good bad | |
PI | hydrostatic | 1 | 6 | good bad | |
PI | period of 12 weeks post-infection | 1 | 6 | good bad | |
PI | product that accumulated was Glc-PO4-Man-Man-GlcN-lyso-1-O-alkylphosphatidylinositol | 1 | 6 | good bad | |
PI | Predictive indicators | 1 | 6 | good bad | |
PI | proliferative index of the epithelium | 1 | 6 | good bad | |
PI | base-pairs upstream | 1 | 5 | good bad | |
PI | putative immune individuals | 1 | 5 | good bad | |
PI | post infectionem | 1 | 5 | good bad | |
PI | PI 3-kinase C2beta utilizes phosphatidylinositol | 1 | 5 | good bad | |
PI | polyphosphoinositides (PPI) but not phosphatidylinositol | 1 | 5 | good bad | |
PI | pixel intensity | 1 | 5 | good bad | |
PI | plus inorganic phosphate | 1 | 5 | good bad | |
PI | protein 2 (CBP2) and alpha-1 antitrypsin | 1 | 5 | good bad | |
PI | proteins differing in isoelectric point | 1 | 5 | good bad | |
PI | progressive incremental | 1 | 5 | good bad | |
PI | penicillin-intermediate | 1 | 5 | good bad | |
PI | pre-inoculation | 1 | 5 | good bad | |
PI | permanently implantable | 1 | 5 | good bad | |
PI | phosphatidylinositol 4-phosphate [PI(4)P] from phosphatidylinositol | 1 | 5 | good bad | |
PI | presence of excess inorganic phosphate | 1 | 5 | good bad | |
PI | pulmonary irritation | 1 | 5 | good bad | |
PI | primary inhibition | 1 | 5 | good bad | |
PI | primary insomnia | 1 | 5 | good bad | |
PI | protease inibithors | 1 | 4 | good bad | |
PI | phosphate residues | 1 | 4 | good bad | |
PI | plasma concentration of inorganic phosphate | 1 | 4 | good bad | |
PI | Like | 1 | 4 | good bad | |
PI | pied | 1 | 4 | good bad | |
PI | prostaglandin inhibition | 1 | 4 | good bad | |
PI | pyrophosphate (PPi) versus phosphate | 1 | 4 | good bad | |
PI | pharmacologic immunosuppressive therapy | 1 | 4 | good bad | |
PI | pixel index | 1 | 4 | good bad | |
PI | plasma colloid osmotic pressure | 1 | 4 | good bad | |
PI | perfusion-weighted | 1 | 4 | good bad | |
PI | V-propidium iodide | 1 | 4 | good bad | |
PI | pathogenic integral | 1 | 4 | good bad | |
PI | plasminogen inactivator | 1 | 4 | good bad | |
PI | phospholipids | 1 | 4 | good bad | |
PI | passive incontinence | 1 | 4 | good bad | |
PI | postero-inferior | 1 | 4 | good bad | |
PI | mGSTP1 | 1 | 4 | good bad | |
PI | postimmunization | 1 | 4 | good bad | |
PI | phospholipid standards phosphatidylinositol | 1 | 4 | good bad | |
PI | potency being phosphatidylinositol | 1 | 4 | good bad | |
PI | proportional and integral | 1 | 4 | good bad | |
PI | peak intensity | 1 | 4 | good bad | |
PI | potease inhibitor | 1 | 4 | good bad | |
PI | pulse inversion (PPI) and pulse inversion | 1 | 4 | good bad | |
PI | prolonged ischemia | 1 | 4 | good bad | |
PI | 1-4GlcN-phosphatidylinositol | 1 | 3 | good bad | |
PI | postinfliction interval | 1 | 3 | good bad | |
PI | pressure-impedance | 1 | 3 | good bad | |
PI | postinoculation of sporozoites | 1 | 3 | good bad | |
PI | potency of phosphatidylinositol | 1 | 3 | good bad | |
PI | protein-interaction | 1 | 3 | good bad | |
PI | psychiatrically-ill | 1 | 3 | good bad | |
PI | protein indices | 1 | 3 | good bad | |
PI | prediction intervals | 1 | 3 | good bad | |
PI | pulsing interval | 1 | 3 | good bad | |
PI | progesterone-independent | 1 | 3 | good bad | |
PI | pyrethrin I | 1 | 3 | good bad | |
PI | positive indices | 1 | 3 | good bad | |
PI | product of the reaction | 1 | 3 | good bad | |
PI | probabilities of Markov process | 1 | 3 | good bad | |
PI | serum-protease-inhibitor | 1 | 3 | good bad | |
PI | promoted amylase secretion and phosphatidylinositol | 1 | 3 | good bad | |
PI | signs--partial imitation | 1 | 3 | good bad | |
PI | pirouette | 1 | 3 | good bad | |
PI | Performance-by-intensity | 1 | 3 | good bad | |
PI | Cd13 | 1 | 3 | good bad | |
PI | pentamidine-isethionate | 1 | 3 | good bad | |
PI | phosphatidyl inositide | 1 | 3 | good bad | |
PI | parameters investigated were plaque index | 1 | 3 | good bad | |
PI | phosphatase hydrolyzing phosphatidylinositol | 1 | 3 | good bad | |
PI | pH at isoelectric point | 1 | 3 | good bad | |
PI | permeability indices | 1 | 3 | good bad | |
PI | acidic | 1 | 3 | good bad | |
PI | permanent illumination | 1 | 3 | good bad | |
PI | permeability-increasing activity | 1 | 2 | good bad | |
PI | phosphoinositidic | 1 | 2 | good bad | |
PI | phosphoinositol | 1 | 2 | good bad | |
PI | protocols incorporated SYBR-14 and propidium iodide | 1 | 2 | good bad | |
PI | phosphorylation and phosphatidylinositol | 1 | 2 | good bad | |
PI | performance | 1 | 2 | good bad | |
PI | perception index | 1 | 2 | good bad | |
PI | Padmakar-Ivan | 1 | 2 | good bad | |
PI | post implant | 1 | 2 | good bad | |
PI | possessed one isoelectric point of | 1 | 2 | good bad | |
PI | peptides induced phosphoinositide | 1 | 2 | good bad | |
PI | patients detected by newborn screening | 1 | 2 | good bad | |
PI | proliferative | 1 | 2 | good bad | |
PI | phosphoenzyme formation from either inorganic orthophosphate | 1 | 2 | good bad | |
PI | prevention indicators | 1 | 2 | good bad | |
PI | periodontal disease | 1 | 2 | good bad | |
PI | phenylephrine-induced contractions and phosphatidylinositol | 1 | 2 | good bad | |
PI | produce beta-lactamases with isoelectric points | 1 | 2 | good bad | |
PI | partial index | 1 | 2 | good bad | |
PI | phonemically implausible | 1 | 2 | good bad | |
PI | proteins with an isoelectric point | 1 | 2 | good bad | |
PI | personal interviews | 1 | 2 | good bad | |
PI | precursor (big ET-1) on phosphoinositide | 1 | 2 | good bad | |
PI | protective index | 1 | 2 | good bad | |
PI | perimeter | 1 | 2 | good bad | |
PI | panoramic index | 1 | 2 | good bad | |
PI | phosphocreatine (PCr)/inorganic orthophosphate | 1 | 2 | good bad | |
PI | Postischemia | 1 | 2 | good bad | |
PI | protein and its locus | 1 | 2 | good bad | |
PI | PDGF addition and one | 1 | 2 | good bad | |
PI | polybutadiene (DPB)/polyisoprene | 1 | 2 | good bad | |
PI | plus insulin | 1 | 2 | good bad | |
PI | pulsativity index | 1 | 2 | good bad | |
PI | Na-phosphate | 1 | 2 | good bad | |
PI | peaks at isoelectric points | 1 | 2 | good bad | |
PI | PCNA index | 1 | 2 | good bad | |
PI | polymer of hundreds of phosphate | 1 | 2 | good bad | |
PI | alpha1-proteinase inhibitor (alpha1 | 1 | 2 | good bad | |
PI | pyritinol on phosphatidylinositol | 1 | 2 | good bad | |
PI | polypeptide with isoelectric point | 1 | 2 | good bad | |
PI | polymorphism data indicated that nucleotide diversity | 1 | 2 | good bad | |
PI | arachidonyl-phosphatidylinositol | 1 | 2 | good bad | |
PI | sigma | 1 | 2 | good bad | |
PI | 5-bisphosphate | 1 | 2 | good bad | |
PI | portal images | 1 | 2 | good bad | |
PI | Pulsatility-Index | 1 | 2 | good bad | |
PI | polymer of hundreds of orthophosphate | 1 | 1 | good bad | |
PI | pathologically increased pulsatility indices | 1 | 1 | good bad | |
PI | phosphate ion | 1 | 1 | good bad | |
PI | phorbol 12-myristate 13-acetate and ionomycin | 1 | 1 | good bad | |
PI | phosphate are known to inhibit Na(+)-phosphate | 1 | 1 | good bad | |
PI | peroxidases with isoelectric point | 1 | 1 | good bad | |
PI | phenotypic distribution of alpha-1-antitrypsin variants | 1 | 1 | good bad | |
PI | partition coefficient | 1 | 1 | good bad | |
PI | partially immune | 1 | 1 | good bad | |
PI | pyromellitimide | 1 | 1 | good bad | |
PI | pressure reading | 1 | 1 | good bad | |
PI | protein isoelectric point | 1 | 1 | good bad | |
PI | PCr/inorganic phosphate | 1 | 1 | good bad | |
PI | protein synthesis and phosphoinositide | 1 | 1 | good bad | |
PI | present in the pars intercerebralis | 1 | 1 | good bad | |
PI | protein's isoelectric point | 1 | 1 | good bad | |
PI | phase | 1 | 1 | good bad | |
PI | phosphate of muscle tissue | 1 | 1 | good bad | |
PI | povidone iodine solution | 1 | 1 | good bad | |
PI | 32P-phosphatidylinositol | 1 | 1 | good bad | |
PI | peaking at day 3 postinoculation | 1 | 1 | good bad | |
PI | N(alpha)-tert-butyloxycarbonyl-N | 1 | 1 | good bad | |
PI | percentage index | 1 | 1 | good bad | |
PI | proliferating indexes | 1 | 1 | good bad | |
PI | Phox (PX) domains are phosphoinositide | 1 | 1 | good bad | |
PI | physical identity | 1 | 1 | good bad | |
PI | pressures | 1 | 1 | good bad | |
PI | Padua Inventory | 1 | 1 | good bad | |
PI | pinhole imaging | 1 | 1 | good bad | |
PI | porphyrins because of a specific metal(d)-porphyrin | 1 | 1 | good bad | |
PI | pineal antigonadotropin | 1 | 1 | good bad | |
PI | p110 subunit of phosphatidylinositol | 1 | 1 | good bad | |
PI | povidone-iodine solution | 1 | 1 | good bad | |
PI | pronounced increase in inorganic phosphate | 1 | 1 | good bad | |
PI | polymorphism | 1 | 1 | good bad | |
PI | proximal intestine | 1 | 1 | good bad | |
PI | phosphodiesters and inorganic phosphate | 1 | 1 | good bad | |
PI | delta | 1 | 1 | good bad | |
PI | post-ischemia | 1 | 1 | good bad | |
PI | puncture (PP) or injection | 1 | 1 | good bad | |
PI | phospholipids phosphatidylethanolamine (PE) and phosphatidylinositol | 1 | 1 | good bad | |
PI | periodic injection | 1 | 0 | good bad | |
PI | PCNA labelling indices | 1 | 0 | good bad | |
PI | patients were scored for plaque | 1 | 0 | good bad | |
PI | production of 3'-phosphorylated phosphoinositide | 1 | 0 | good bad | |
PI | Prolongation Index | 1 | 0 | good bad | |
PI | Periodontal indices utilized were Plaque Index | 1 | 0 | good bad | |
PI | patency on day 8 postinfection | 1 | 0 | good bad | |
PI | prostaglandin (PG) F2 alpha-stimulated phosphoinositide | 1 | 0 | good bad | |
PI | prognostic indexes | 1 | 0 | good bad | |
PI | proportion index | 1 | 0 | good bad | |
PI | procedure generates unconventional surface pressure | 1 | 0 | good bad | |
PI | [32P]orthophosphate | 1 | 0 | good bad | |
PI | prognostic | 1 | 0 | good bad | |
PI | pectin-insulin | 1 | 0 | good bad | |
PI | peak interval | 1 | 0 | good bad | |
PI | periodontal conditions | 1 | 0 | good bad | |
PI | alpha1-protease inhibitor | 1 | 0 | good bad | |
PI | phosphorylation of phosphatidylinositol | 1 | 0 | good bad | |
PI | positive affect | 1 | 0 | good bad | |
PI | Physical Impairment | 1 | 0 | good bad | |
PI | positivity index | 1 | 0 | good bad | |
PI | pi-back-bonding from the Fe d | 1 | 0 | good bad | |
PI | position of the inorganic phosphate | 1 | 0 | good bad | |
PI | pirimicarb | 1 | 0 | good bad | |
PI | porcine | 1 | 0 | good bad | |
PI | PAI-1 is due to phosphatidylinositol | 1 | 0 | good bad | |
PI | purulent intoxication | 1 | 0 | good bad | |
PI | poly-phosphoinositides | 1 | 0 | good bad | |
PI | placebo group | 1 | 0 | good bad | |
PI | planar imaging | 1 | 0 | good bad | |
PI | PME isoforms exhibiting a wide isoelectric-point | 1 | 0 | good bad | |
PI | plus ifosfamide | 1 | 0 | good bad | |
PI | plethysmography index | 1 | 0 | good bad | |
PI | psychosocial intervention | 1 | 0 | good bad | |
PI | pancreatic exocrine insufficiency | 1 | 0 | good bad | |
PI | partially filled porphyrin 3e | 1 | 0 | good bad | |
PI | protein with isoelectric point | 1 | 0 | good bad | |
PI | pressure caused by colloid osmotic forces | 1 | 0 | good bad | |
PI | perturbations in phosphoinositide | 1 | 0 | good bad | |
PI | protein kinase and phosphatidylinositol | 1 | 0 | good bad | |
PI | pressurized hand-held inhaler | 1 | 0 | good bad | |
PI | presynaptic inhibition | 1 | 0 | good bad | |
PI | Prevention indexes | 1 | 0 | good bad | |
PI | Parsonnet index | 1 | 0 | good bad | |
PI | persistent increase in phosphoinositide | 1 | 0 | good bad | |
PI | pseudo-intima | 1 | 0 | good bad | |
PI | pseudointima | 1 | 0 | good bad | |
PI | phosphoinositide hydrolysis | 1 | 0 | good bad | |
PI | phosphoglycerides phosphatidylinositol | 1 | 0 | good bad | |
PI | phosphatidylinositol pathway | 1 | 0 | good bad | |
PI | pacemaker-independent | 1 | -1 | good bad | |
PI | Proteins within an isoelectric point | 1 | -1 | good bad | |
PI | pattern I by Appleton | 1 | -1 | good bad | |
PI | poly[-6-beta-D-glucopyranosyl-(1-->2)-glycerol phosphate] | 1 | -1 | good bad | |
PI | GlcN-phosphatidylinositol | 1 | -1 | good bad | |
PI | proteins with iso-electric points | 1 | -1 | good bad | |
PI | patients treated with HIV-protease inhibitors | 1 | -1 | good bad | |
PI | portal infusion | 1 | -1 | good bad | |
PI | phospholipase C-gamma2 (PLC-gamma2) and phosphatidylinositol | 1 | -1 | good bad | |
PI | Phosphocreatine (PCr)/inorganic phosphate | 1 | -1 | good bad | |
PI | Placebo | 1 | -1 | good bad | |
PI | phosphatidylinositol hydrolysis | 1 | -1 | good bad | |
PI | power density | 1 | -1 | good bad | |
PI | polyimide | 1 | -1 | good bad | |
PI | positively linked to phosphoinositide | 1 | -1 | good bad | |
PI | prescribing information | 1 | -1 | good bad | |
PI | pituitary isografts | 1 | -1 | good bad | |
PI | post-injection | 1 | -1 | good bad | |
PI | Pilocarpine increased in vivo phosphoinositide | 1 | -1 | good bad | |
PI | Pool I | 1 | -1 | good bad | |
PI | Phytophthora infestans | 1 | -1 | good bad | |
PI | physical intimidation | 1 | -1 | good bad | |
PI | phosphotidylinositol | 1 | -1 | good bad | |
PI | polysomy index | 1 | -1 | good bad | |
PI | post-initial infection | 1 | -1 | good bad | |
PI | pituitary | 1 | -1 | good bad | |
PI | plaque/calculus index | 1 | -1 | good bad | |
PI | processing-independent | 1 | -1 | good bad | |
PI | phosphorylating phosphatidylinositol | 1 | -1 | good bad | |
PI | produced when inorganic phosphate | 1 | -1 | good bad | |
PI | pepsin | 1 | -1 | good bad | |
PI | peritoneal irritation | 1 | -1 | good bad | |
PI | plasma inorganic P | 1 | -1 | good bad | |
PI | plasma inorganic phosphorus | 1 | -1 | good bad | |
PI | primary | 1 | -1 | good bad | |
PI | pressure of the pleural liquid | 1 | -1 | good bad | |
PI | prophase I | 1 | -1 | good bad | |
PI | plasma Ca++ and inorganic P | 1 | -1 | good bad | |
PI | pressure in capillaries (Pc) and interstitium | 1 | -1 | good bad | |
PI | peaking 7 days postinfection | 1 | -1 | good bad | |
PI | proportional-plus-integral | 1 | -1 | good bad | |
PI | protein identity | 1 | -2 | good bad | |
PI | trypsin-2-alpha1-proteinase inhibitor | 1 | -2 | good bad | |
PI | plasma membrane by phosphatidylinositol | 1 | -2 | good bad | |
PI | PLC-mediated phosphoinositide | 1 | -2 | good bad | |
PI | polymorphic immunocytoma | 1 | -2 | good bad | |
PI | platelet increment | 1 | -2 | good bad | |
PI | placental insufficiency | 1 | -2 | good bad | |
PI | pyrophosphate (PPi) and inorganic orthophosphate | 1 | -2 | good bad | |
PI | alpha1-proteinase inhibitor | 1 | -2 | good bad | |
PI | porcine insulin | 1 | -2 | good bad | |
PI | porcine influenza virus | 1 | -2 | good bad | |
PI | P induced phosphatidylinositol | 1 | -2 | good bad | |
PI | presence of intranucleaur pseudo-inclusion bodies | 1 | -2 | good bad | |
PI | pressure (Pv) on interstitial fluid hydrostatic | 1 | -2 | good bad | |
PI | protein of isoelectric point | 1 | -2 | good bad | |
PI | pressure irrigation | 1 | -2 | good bad | |
PI | patients with Parkinson's disease | 1 | -2 | good bad | |
PI | Patient Identified | 1 | -2 | good bad | |
PI | peptides to stimulate phosphoinositide | 1 | -2 | good bad | |
PI | Pearl Index | 1 | -2 | good bad | |
PI | presence of (32P) inorganic phosphate | 1 | -2 | good bad | |
PI | prescription isodose volume | 1 | -2 | good bad | |
PI | prematurity index | 1 | -2 | good bad | |
PI | pulmonary infiltration | 1 | -2 | good bad | |
PI | palmar interosseous | 1 | -2 | good bad | |
PI | perfusion indices | 1 | -2 | good bad | |
PI | phosphatidylserine (PS) and phosphatidylositol | 1 | -2 | good bad | |
PI | phosphatidylserine (PS) and phosphatidylinositol | 1 | -2 | good bad | |
PI | phosphate concentrations | 1 | -2 | good bad | |
PI | pars interpolaris | 1 | -2 | good bad | |
PI | propidium iodine (BrdU) | 1 | -2 | good bad |
|
Text2Knowledge ... Yong Huang
2002
|